Andrew R. Robbins
President and CEO at Cogent Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cogent Biosciences Inc., 3 years.
Cogent Biosciences Inc.
Director · President and CEO
Chief executive roles
Cogent Biosciences Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 2026 | Cogent Biosciences Inc. | Gift | −160,000 | — | — |
| May 19, 2026 | Cogent Biosciences Inc. | Gift | +160,000 | — | — |
| Dec 17, 2025 | Cogent Biosciences Inc. | Grant or award | +185,000 | — | — |
| Dec 17, 2025 | Cogent Biosciences Inc. | Grant or award | +840,000 | — | — |
| Dec 17, 2025 | Cogent Biosciences Inc. | Shares withheld for tax | −367,497 | $39.45 | $14,497,757 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.